FDA alerts more doctors of rare cancer with breast implants

U.S. health officials say doctors should be on the lookout for a rare cancer linked to breast implants after receiving more reports of the disease.

The Food and Drug Administration sent a letter late Wednesday to family doctors, nurses and other warning about the form of lymphoma in breast implant patients. In suspected cases, the FDA recommends laboratory testing to confirm or rule out of the disease. It's the first time regulators have issued such a warning to doctors other than plastic surgeons.

The disease is not breast cancer, but usually forms in the that forms around implants.

Regulators said they have identified 450 likely cases of the cancer since 2010. That's a tiny number considering 400,000 U.S. women receive implants annually.

Explore further

Nine US deaths linked to breast implant-associated cancer

© 2019 The Associated Press. All rights reserved.

Citation: FDA alerts more doctors of rare cancer with breast implants (2019, February 7) retrieved 25 October 2021 from https://medicalxpress.com/news/2019-02-fda-doctors-rare-cancer-breast.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors